Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription corepressor activity	ATN1 CBFA2T2 GON4L RERE MIDEAS RBFOX2	1.75e-05	229	48	6	GO:0003714
GeneOntologyMolecularFunction	transcription coregulator activity	LDB1 ATN1 CBFA2T2 GON4L SMARCC2 RERE MIDEAS RBFOX2	5.24e-05	562	48	8	GO:0003712
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	LDB1 ATN1 RBM33 CBFA2T2 GON4L SMARCC2 IRS2 SH2D2A RERE MIDEAS RBFOX2	7.50e-05	1160	48	11	GO:0030674
GeneOntologyMolecularFunction	protein domain specific binding	ZNF384 LDB1 ATN1 WIPF1 PHRF1 IRS2 SH2D2A GNAS BCAR1	2.06e-04	875	48	9	GO:0019904
GeneOntologyMolecularFunction	molecular adaptor activity	LDB1 ATN1 RBM33 CBFA2T2 GON4L SMARCC2 IRS2 SH2D2A RERE MIDEAS RBFOX2	2.97e-04	1356	48	11	GO:0060090
GeneOntologyMolecularFunction	SH3 domain binding	ZNF384 WIPF1 SH2D2A BCAR1	3.84e-04	143	48	4	GO:0017124
GeneOntologyCellularComponent	beta-catenin-TCF complex	TCF7 LDB1	3.80e-04	13	47	2	GO:1990907
GeneOntologyCellularComponent	RSC-type complex	PBRM1 SMARCC2	5.10e-04	15	47	2	GO:0016586
GeneOntologyCellularComponent	COPII vesicle coat	SEC24D SEC24A	5.82e-04	16	47	2	GO:0030127
GeneOntologyCellularComponent	cell leading edge	ERBB2 LDB1 ATN1 WIPF1 GNAS BCAR1	8.49e-04	500	47	6	GO:0031252
GeneOntologyCellularComponent	ruffle	ERBB2 WIPF1 GNAS BCAR1	1.17e-03	206	47	4	GO:0001726
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	PBRM1 GON4L SMARCC2	1.31e-03	96	47	3	GO:0070603
GeneOntologyCellularComponent	SWI/SNF complex	PBRM1 SMARCC2	2.07e-03	30	47	2	GO:0016514
Domain	MYB_LIKE	GON4L SMARCC2 RERE MIDEAS	2.66e-06	38	48	4	PS50090
Domain	Atrophin-like	ATN1 RERE	6.47e-06	2	48	2	IPR002951
Domain	Atrophin-1	ATN1 RERE	6.47e-06	2	48	2	PF03154
Domain	SANT	GON4L SMARCC2 RERE MIDEAS	8.11e-06	50	48	4	SM00717
Domain	SANT/Myb	GON4L SMARCC2 RERE MIDEAS	9.49e-06	52	48	4	IPR001005
Domain	SANT_dom	SMARCC2 RERE MIDEAS	3.97e-05	26	48	3	IPR017884
Domain	SANT	SMARCC2 RERE MIDEAS	4.99e-05	28	48	3	PS51293
Domain	HMGI/Y_DNA-bd_CS	PRR12 PRB3 PRB4	6.81e-05	31	48	3	IPR000637
Domain	Sec23/24_helical_dom	SEC24D SEC24A	9.64e-05	6	48	2	IPR006900
Domain	Sec23/24_trunk_dom	SEC24D SEC24A	9.64e-05	6	48	2	IPR006896
Domain	Znf_Sec23_Sec24	SEC24D SEC24A	9.64e-05	6	48	2	IPR006895
Domain	Sec23_24_beta_S	SEC24D SEC24A	9.64e-05	6	48	2	IPR012990
Domain	zf-Sec23_Sec24	SEC24D SEC24A	9.64e-05	6	48	2	PF04810
Domain	Sec23_trunk	SEC24D SEC24A	9.64e-05	6	48	2	PF04811
Domain	Sec23_helical	SEC24D SEC24A	9.64e-05	6	48	2	PF04815
Domain	Sec23_BS	SEC24D SEC24A	9.64e-05	6	48	2	PF08033
Domain	Myb_DNA-binding	SMARCC2 RERE MIDEAS	9.84e-05	35	48	3	PF00249
Domain	BAH	PBRM1 RERE	3.51e-04	11	48	2	SM00439
Domain	BAH	PBRM1 RERE	3.51e-04	11	48	2	PF01426
Domain	BAH_dom	PBRM1 RERE	3.51e-04	11	48	2	IPR001025
Domain	BAH	PBRM1 RERE	3.51e-04	11	48	2	PS51038
Domain	ELM2	RERE MIDEAS	4.95e-04	13	48	2	SM01189
Domain	ELM2	RERE MIDEAS	4.95e-04	13	48	2	PF01448
Domain	ELM2	RERE MIDEAS	4.95e-04	13	48	2	PS51156
Domain	ELM2_dom	RERE MIDEAS	4.95e-04	13	48	2	IPR000949
Domain	Gelsolin	SEC24D SEC24A	5.77e-04	14	48	2	PF00626
Domain	Gelsolin-like_dom	SEC24D SEC24A	5.77e-04	14	48	2	IPR007123
Domain	WH2	WIPF1 WIPF2	5.77e-04	14	48	2	SM00246
Domain	WH2	WIPF1 WIPF2	7.58e-04	16	48	2	PF02205
Domain	WH2_dom	WIPF1 WIPF2	1.32e-03	21	48	2	IPR003124
Domain	-	SEC24D SEC24A	1.72e-03	24	48	2	3.40.20.10
Domain	WH2	WIPF1 WIPF2	1.72e-03	24	48	2	PS51082
Domain	ADF-H/Gelsolin-like_dom	SEC24D SEC24A	1.72e-03	24	48	2	IPR029006
Domain	HMG_box	TCF7 PBRM1	8.20e-03	53	48	2	PF00505
Domain	HMG_BOX_2	TCF7 PBRM1	8.50e-03	54	48	2	PS50118
Domain	HMG	TCF7 PBRM1	8.50e-03	54	48	2	SM00398
Domain	-	TCF7 PBRM1	8.81e-03	55	48	2	1.10.30.10
Domain	-	RERE NR2F2	9.43e-03	57	48	2	3.30.50.10
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	PRR12 PBRM1 CHERP LDB1 ATN1 GSE1 RBM33 SMARCC2 RERE MIDEAS	3.94e-12	268	49	10	33640491
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	PRR12 ERBB2 CHERP LDB1 GSE1 RBM33 KHSRP	6.33e-09	180	49	7	35198878
Pubmed	Human transcription factor protein interaction networks.	PRR12 TCF7 PBRM1 LDB1 ATN1 GSE1 RBM33 SEC24A GON4L SMARCC2 RERE MIDEAS CCDC86 TFCP2	6.42e-09	1429	49	14	35140242
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	COL18A1 ERBB2 TCF7 CHERP RBM33 CBFA2T2 PRR13 GON4L GNAS BCAR1 WIPF2 RBFOX2 OPLAH	8.83e-09	1215	49	13	15146197
Pubmed	Interaction network of human early embryonic transcription factors.	PRR12 PBRM1 LDB1 ATN1 GSE1 SMARCC2 RERE MIDEAS	3.13e-08	351	49	8	38297188
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	PRR12 LDB1 ATN1 GSE1 RBM33 MIDEAS	7.56e-08	152	49	6	38360978
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	PCED1A ZNF384 ATN1 EFEMP2 PRR13 SMARCC2 TFCP2 RBFOX2 OPLAH	7.91e-08	560	49	9	21653829
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATN1 GSE1 CBFA2T2 PHRF1 SMARCC2 IRS2 RERE CCDC86 MN1	1.18e-06	774	49	9	15302935
Pubmed	p130Cas is an essential transducer element in ErbB2 transformation.	ERBB2 BCAR1	1.94e-06	2	49	2	20505116
Pubmed	Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine.	ATN1 RERE	1.94e-06	2	49	2	10814707
Pubmed	Identification of Lys-Pro-Gln as a novel cleavage site specificity of saliva-associated proteases.	PRB3 PRB4	1.94e-06	2	49	2	18463091
Pubmed	Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells.	ERBB2 BCAR1	1.94e-06	2	49	2	23839042
Pubmed	WIP and WICH/WIRE co-ordinately control invadopodium formation and maturation in human breast cancer cell invasion.	WIPF1 WIPF2	1.94e-06	2	49	2	27009365
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	LDB1 ATN1 CBFA2T2 EFEMP2 SMARCC2 RERE TFCP2 RBFOX2	2.00e-06	608	49	8	16713569
Pubmed	WW domains provide a platform for the assembly of multiprotein networks.	CHERP WIPF1 SMARCC2 WIPF2 KHSRP	2.60e-06	154	49	5	16055720
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	LDB1 GSE1 NFATC1 CBFA2T2 SMARCC2 CCDC86 TFCP2 NR2F2 KHSRP	2.73e-06	857	49	9	25609649
Pubmed	Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.	SMARCC2 MIDEAS TFCP2 NR2F2	4.36e-06	77	49	4	19505873
Pubmed	Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.	PRR12 GSE1 SMARCC2 TFCP2 KHSRP	5.13e-06	177	49	5	26206133
Pubmed	Molecular genetics of human salivary proteins and their polymorphisms.	PRB3 PRB4	5.83e-06	3	49	2	3055850
Pubmed	Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.	ERBB2 BCAR1	5.83e-06	3	49	2	28442738
Pubmed	Atrophin proteins interact with the Fat1 cadherin and regulate migration and orientation in vascular smooth muscle cells.	ATN1 RERE	5.83e-06	3	49	2	19131340
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	PRR12 ZNF384 GSE1 MIDEAS	5.89e-06	83	49	4	28794006
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	LDB1 GSE1 CBFA2T2	1.04e-05	30	49	3	26593974
Pubmed	cDNA clones for mouse parotid proline-rich proteins. mRNA regulation by isoprenaline and the nucleotide sequence of proline-rich protein cDNA MP5.	PRB3 PRB4	1.16e-05	4	49	2	1339347
Pubmed	Finding new posttranslational modifications in salivary proline-rich proteins.	PRB3 PRB4	1.16e-05	4	49	2	20879038
Pubmed	Insulin stimulates the tyrosine dephosphorylation of docking protein p130cas (Crk-associated substrate), promoting the switch of the adaptor protein crk from p130cas to newly phosphorylated insulin receptor substrate-1.	IRS2 BCAR1	1.16e-05	4	49	2	9729467
Pubmed	p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.	ERBB2 BCAR1	1.16e-05	4	49	2	20961652
Pubmed	The involvement of proline-rich protein Mus musculus predicted gene 4736 in ocular surface functions.	PRB3 PRB4	1.16e-05	4	49	2	27588265
Pubmed	p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.	ERBB2 BCAR1	1.16e-05	4	49	2	26716506
Pubmed	Functional architecture of atrophins.	ATN1 RERE	1.16e-05	4	49	2	17150957
Pubmed	Length polymorphisms in human proline-rich protein genes generated by intragenic unequal crossing over.	PRB3 PRB4	1.16e-05	4	49	2	2851479
Pubmed	A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer.	ERBB2 GNAS	1.16e-05	4	49	2	34110646
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	PBRM1 GSE1 RERE MIDEAS KHSRP	1.47e-05	220	49	5	35785414
Pubmed	Cyanidin-3-glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2.	ERBB2 BCAR1	1.94e-05	5	49	2	21034468
Pubmed	Enteropathogenic Escherichia coli and vaccinia virus do not require the family of WASP-interacting proteins for pathogen-induced actin assembly.	WIPF1 WIPF2	1.94e-05	5	49	2	22966049
Pubmed	The intriguing heterogeneity of human salivary proline-rich proteins: Short title: Salivary proline-rich protein species.	PRB3 PRB4	1.94e-05	5	49	2	26375204
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	PRR12 PBRM1 CHERP CBFA2T2 SMARCC2 CCDC86 TFCP2 NR2F2	2.23e-05	847	49	8	35850772
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	ZNF384 TCF7 LDB1 CBFA2T2 RERE TFCP2 NR2F2 RBFOX2	2.86e-05	877	49	8	20211142
Pubmed	Variations in the composition of mammalian SWI/SNF chromatin remodelling complexes.	PBRM1 SMARCC2	2.91e-05	6	49	2	19650111
Pubmed	Sec24 proteins and sorting at the endoplasmic reticulum.	SEC24D SEC24A	2.91e-05	6	49	2	10075675
Pubmed	Mouse model reveals the role of RERE in cerebellar foliation and the migration and maturation of Purkinje cells.	RERE NR2F2	2.91e-05	6	49	2	24466353
Pubmed	Differential RNA splicing and post-translational cleavages in the human salivary proline-rich protein gene system.	PRB3 PRB4	2.91e-05	6	49	2	2993301
Pubmed	A family of mammalian proteins homologous to yeast Sec24p.	SEC24D SEC24A	2.91e-05	6	49	2	10329445
Pubmed	Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.	GSE1 RERE MIDEAS	3.58e-05	45	49	3	21258344
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	COL18A1 ERBB2 LDB1 NFATC1 MBNL2 CBFA2T2 RERE GNAS BCAR1 RBFOX2	3.58e-05	1489	49	10	28611215
Pubmed	A census of human transcription factors: function, expression and evolution.	ZNF384 TCF7 NFATC1 GON4L RERE MIDEAS TFCP2 NR2F2	3.66e-05	908	49	8	19274049
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF384 PBRM1 CHERP ATN1 GSE1 RBM33 SMARCC2 RERE GNAS	4.06e-05	1203	49	9	29180619
Pubmed	Selective export of human GPI-anchored proteins from the endoplasmic reticulum.	SEC24D SEC24A	4.07e-05	7	49	2	20427317
Pubmed	Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors.	ATN1 RERE	4.07e-05	7	49	2	16481466
Pubmed	Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity.	ATN1 RERE	4.07e-05	7	49	2	22510986
Pubmed	A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization.	COL18A1 EFEMP2	4.07e-05	7	49	2	17324935
Pubmed	Suppression of bone formation by osteoclastic expression of semaphorin 4D.	ERBB2 NFATC1	4.07e-05	7	49	2	22019888
Pubmed	Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.	LDB1 CBFA2T2	4.07e-05	7	49	2	19799863
Pubmed	Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy.	KCNA5 ATN1 GNAS CCDC86	4.25e-05	137	49	4	30862715
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	PRR12 ATN1 GSE1 RBM33 SEC24A MIDEAS	4.32e-05	457	49	6	32344865
Pubmed	Substrate-trapping techniques in the identification of cellular PTP targets.	KCNA5 IRS2 BCAR1	4.63e-05	49	49	3	15588985
Pubmed	Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor.	SEC24D CHERP SMARCC2	4.92e-05	50	49	3	27716508
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZNF384 CHERP MBNL2 RBM33 SMARCC2 MIDEAS CCDC86 KHSRP	5.18e-05	954	49	8	36373674
Pubmed	CHD7 cooperates with PBAF to control multipotent neural crest formation.	PBRM1 SMARCC2	5.42e-05	8	49	2	20130577
Pubmed	The assembly of mammalian SWI/SNF chromatin remodeling complexes is regulated by lysine-methylation dependent proteolysis.	PBRM1 SMARCC2	5.42e-05	8	49	2	36335117
Pubmed	Single-cell analysis of early progenitor cells that build coronary arteries.	NFATC1 NR2F2	5.42e-05	8	49	2	29973725
Pubmed	Upstream distal regulatory elements contact the Lmo2 promoter in mouse erythroid cells.	LDB1 CBFA2T2	5.42e-05	8	49	2	23285212
Pubmed	The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer.	PBRM1 SMARCC2	5.42e-05	8	49	2	28940253
Pubmed	SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion.	SEC24D SEC24A	5.42e-05	8	49	2	23580231
Pubmed	DOT1L deletion impairs the development of cortical parvalbumin-expressing interneurons.	RPP25 LDB1 NR2F2	5.53e-05	52	49	3	37566909
Pubmed	Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT).	PBRM1 CHERP NR2F2	6.55e-05	55	49	3	27114453
Pubmed	Notch signaling regulates Hey2 expression in a spatiotemporal dependent manner during cardiac morphogenesis and trabecular specification.	ERBB2 NFATC1	6.96e-05	9	49	2	29422515
Pubmed	Precise temporal regulation of alternative splicing during neural development.	MBNL2 RBFOX2	6.96e-05	9	49	2	29875359
Pubmed	Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer.	PBRM1 SMARCC2	6.96e-05	9	49	2	30355451
Pubmed	Members of the Zyxin family of LIM proteins interact with members of the p130Cas family of signal transducers.	RERE BCAR1	6.96e-05	9	49	2	11782456
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	CHERP LRCH2 RBM33 SMARCC2 WIPF2 KHSRP	7.58e-05	506	49	6	30890647
Pubmed	The transport signal on Sec22 for packaging into COPII-coated vesicles is a conformational epitope.	SEC24D SEC24A	8.69e-05	10	49	2	17499046
Pubmed	Structural basis of cargo membrane protein discrimination by the human COPII coat machinery.	SEC24D SEC24A	8.69e-05	10	49	2	18843296
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	PBRM1 SMARCC2 MIDEAS TFCP2	9.18e-05	167	49	4	20362541
Pubmed	Endocardial Hippo signaling regulates myocardial growth and cardiogenesis.	ERBB2 NFATC1	1.06e-04	11	49	2	29727635
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	COL18A1 PBRM1 SMARCC2 GNAS MIDEAS CCDC86 WIPF2 TFCP2 KHSRP	1.11e-04	1371	49	9	36244648
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ZNF384 GSE1 SMARCC2 MIDEAS KHSRP	1.18e-04	341	49	5	32971831
Pubmed	Planar cell polarity defects and defective Vangl2 trafficking in mutants for the COPII gene Sec24b.	SEC24D SEC24A	1.27e-04	12	49	2	20215345
Pubmed	RERE deficiency leads to decreased expression of GATA4 and the development of ventricular septal defects.	NFATC1 RERE	1.27e-04	12	49	2	30061196
Pubmed	Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event.	PBRM1 CHERP SMARCC2 CCDC86	1.28e-04	182	49	4	26527279
Pubmed	FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ.	ZNF384 LDB1 NFATC1 SMARCC2	1.31e-04	183	49	4	36129980
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	TCF7 PBRM1 LDB1 NFATC1 MBNL2 TFCP2 NR2F2	1.31e-04	808	49	7	20412781
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	ZNF384 COL18A1 CCDC86 TFCP2 NR2F2	1.31e-04	349	49	5	25665578
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	PRR12 ZNF384 GSE1 WIPF1 RBM33 SMARCC2 MIDEAS KHSRP	1.42e-04	1103	49	8	34189442
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PRR12 ZNF384 ERBB2 NFATC1 SLC35A2 IRS2 CHPF NR2F2	1.44e-04	1105	49	8	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ERBB2 PBRM1 ATN1 GSE1 PHRF1 SMARCC2 IRS2 RERE	1.54e-04	1116	49	8	31753913
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	ZNF384 CHERP LDB1 NFATC1 TFCP2 NR2F2	1.64e-04	583	49	6	29844126
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	SEC24D CHERP ATN1 RBM33 SEC24A EFEMP2 SMARCC2 RERE GNAS	1.70e-04	1451	49	9	30550785
Pubmed	Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome.	PBRM1 SMARCC2	1.75e-04	14	49	2	36289231
Pubmed	Purification and biochemical heterogeneity of the mammalian SWI-SNF complex.	PBRM1 SMARCC2	1.75e-04	14	49	2	8895581
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	GSE1 SMARCC2 RBFOX2	1.86e-04	78	49	3	28611094
Pubmed	Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways.	PBRM1 SMARCC2	2.02e-04	15	49	2	23785148
Pubmed	An essential switch in subunit composition of a chromatin remodeling complex during neural development.	PBRM1 SMARCC2	2.02e-04	15	49	2	17640523
Pubmed	PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes.	PBRM1 SMARCC2	2.02e-04	15	49	2	15985610
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	PBRM1 GON4L SMARCC2 MIDEAS CCDC86	2.30e-04	394	49	5	27248496
Pubmed	Arterialization requires the timely suppression of cell growth.	NFATC1 NR2F2	2.30e-04	16	49	2	33299176
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	PBRM1 CHERP SMARCC2 CCDC86 KHSRP	2.36e-04	396	49	5	26687479
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	PRR12 PBRM1 GON4L SMARCC2 TFCP2	2.41e-04	398	49	5	35016035
Pubmed	Identification of a polymorphic, neuron-specific chromatin remodeling complex.	PBRM1 SMARCC2	2.61e-04	17	49	2	12368262
Pubmed	The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes.	PBRM1 SMARCC2	2.61e-04	17	49	2	11078522
Interaction	SP7 interactions	PRR12 PBRM1 LDB1 ATN1 GSE1 RBM33 SMARCC2 RERE MIDEAS	4.35e-08	304	49	9	int:SP7
Interaction	MEN1 interactions	PRR12 ZNF384 PBRM1 CHERP ATN1 GSE1 CBFA2T2 SMARCC2 RERE MIDEAS CCDC86 TFCP2 NR2F2 KHSRP	9.46e-08	1029	49	14	int:MEN1
Interaction	TLE3 interactions	PRR12 CHERP LDB1 ATN1 GSE1 SEC24A SMARCC2 RERE MIDEAS	2.65e-07	376	49	9	int:TLE3
Interaction	TBXT interactions	PRR12 LDB1 ATN1 GSE1 SMARCC2 MIDEAS	3.65e-07	116	49	6	int:TBXT
Interaction	AR interactions	PRR12 PBRM1 CHERP LDB1 ATN1 GSE1 RBM33 SMARCC2 SH2D2A RERE GNAS MIDEAS KHSRP	4.63e-07	992	49	13	int:AR
Interaction	GATA2 interactions	PRR12 PBRM1 LDB1 GSE1 NFATC1 SMARCC2 MIDEAS	4.98e-07	199	49	7	int:GATA2
Interaction	PAX9 interactions	PRR12 PBRM1 LDB1 ATN1 GSE1 MIDEAS	7.15e-07	130	49	6	int:PAX9
Interaction	TLX2 interactions	PRR12 PBRM1 LDB1 GSE1 MIDEAS CCDC86	1.20e-06	142	49	6	int:TLX2
Interaction	GSC interactions	PRR12 LDB1 ATN1 RERE MIDEAS	2.19e-06	87	49	5	int:GSC
Interaction	SNRNP40 interactions	ZNF384 CHERP ATN1 GSE1 PHRF1 GON4L SMARCC2 MIDEAS RBFOX2 KHSRP	2.50e-06	637	49	10	int:SNRNP40
Interaction	RERE interactions	ATN1 CBFA2T2 EFEMP2 RERE RBFOX2	3.05e-06	93	49	5	int:RERE
Interaction	EGR2 interactions	PRR12 LDB1 ATN1 NFATC1 RERE MIDEAS	3.53e-06	171	49	6	int:EGR2
Interaction	PLSCR1 interactions	PCED1A ATN1 EFEMP2 PRR13 SLC35A2 RERE	3.65e-06	172	49	6	int:PLSCR1
Interaction	TLX1 interactions	PRR12 PBRM1 LDB1 ATN1 GSE1 MIDEAS	4.04e-06	175	49	6	int:TLX1
Interaction	ALG13 interactions	PRR12 ATN1 GSE1 RBM33 RERE RBFOX2	5.22e-06	183	49	6	int:ALG13
Interaction	TLX3 interactions	PRR12 PBRM1 LDB1 GSE1 EFEMP2 RERE MIDEAS	6.22e-06	291	49	7	int:TLX3
Interaction	PAX8 interactions	PRR12 PBRM1 LDB1 GSE1 MIDEAS	7.28e-06	111	49	5	int:PAX8
Interaction	MYOD1 interactions	PRR12 PBRM1 GSE1 SMARCC2 MIDEAS NR2F2	7.30e-06	194	49	6	int:MYOD1
Interaction	APBB1 interactions	ERBB2 CHERP WIPF1 WIPF2 TFCP2 KHSRP	7.52e-06	195	49	6	int:APBB1
Interaction	DTX2 interactions	PRR12 ERBB2 CHERP LDB1 GSE1 RBM33 KHSRP	1.41e-05	330	49	7	int:DTX2
Interaction	ERG interactions	PRR12 LDB1 GSE1 SMARCC2 RERE MIDEAS	1.61e-05	223	49	6	int:ERG
Interaction	RBPMS interactions	RPP25 ATN1 GSE1 MBNL2 EFEMP2 SMARCC2 RBFOX2	1.71e-05	340	49	7	int:RBPMS
Interaction	NUP50 interactions	ZNF384 PBRM1 GSE1 RBM33 SMARCC2 NR2F2 KHSRP	1.74e-05	341	49	7	int:NUP50
Interaction	GCM1 interactions	PRR12 GSE1 SMARCC2 MIDEAS	2.24e-05	68	49	4	int:GCM1
Interaction	EYA4 interactions	PRR12 LDB1 ATN1 GSE1 RBM33 MIDEAS	2.62e-05	243	49	6	int:EYA4
Interaction	CRX interactions	PRR12 PBRM1 LDB1 ATN1 RERE MIDEAS	3.36e-05	254	49	6	int:CRX
Interaction	CBFA2T3 interactions	LDB1 GSE1 SEC24A CBFA2T2	3.85e-05	78	49	4	int:CBFA2T3
Interaction	ESRRB interactions	PRR12 ERBB2 PBRM1 SMARCC2 TFCP2 KHSRP	3.99e-05	262	49	6	int:ESRRB
Interaction	PIK3R1 interactions	ERBB2 MAP6 SMARCC2 IRS2 SH2D2A BCAR1 KHSRP	5.81e-05	412	49	7	int:PIK3R1
Interaction	NUP35 interactions	PRR12 ATN1 GSE1 RBM33 SEC24A BCAR1 MIDEAS	6.96e-05	424	49	7	int:NUP35
Interaction	SOX17 interactions	PRR12 PBRM1 LDB1 MIDEAS	8.34e-05	95	49	4	int:SOX17
Interaction	LHX3 interactions	PRR12 PBRM1 LDB1 GSE1 MIDEAS	8.49e-05	185	49	5	int:LHX3
Interaction	ATN1 interactions	ATN1 CBFA2T2 EFEMP2 RERE RBFOX2	8.93e-05	187	49	5	int:ATN1
Interaction	STMN2 interactions	ERBB2 SEC24A SMARCC2 TFCP2	9.05e-05	97	49	4	int:STMN2
Interaction	SOX9 interactions	PRR12 PBRM1 SMARCC2 MIDEAS	9.05e-05	97	49	4	int:SOX9
Interaction	SS18L1 interactions	TCF7 PBRM1 ATN1 SMARCC2	9.42e-05	98	49	4	int:SS18L1
Interaction	HNF1B interactions	PRR12 PBRM1 LDB1 GSE1 MIDEAS	9.62e-05	190	49	5	int:HNF1B
Interaction	ZMYND8 interactions	ERBB2 CHERP ATN1 GSE1 RERE	9.87e-05	191	49	5	int:ZMYND8
Interaction	NR2E1 interactions	ATN1 GSE1 RERE	1.07e-04	38	49	3	int:NR2E1
Interaction	SH3KBP1 interactions	SEC24D ERBB2 WIPF1 BCAR1 MIDEAS WIPF2	1.10e-04	315	49	6	int:SH3KBP1
Interaction	UHRF2 interactions	ZNF384 PBRM1 CHERP BCAR1 NR2F2	1.22e-04	200	49	5	int:UHRF2
Interaction	FEV interactions	PRR12 PBRM1 LDB1 GSE1 MIDEAS	1.31e-04	203	49	5	int:FEV
Interaction	TOP3B interactions	PRR12 ZNF384 ERBB2 NFATC1 RBM33 SEC24A SLC35A2 IRS2 GNAS CHPF TFCP2 NR2F2	1.59e-04	1470	49	12	int:TOP3B
Interaction	TBR1 interactions	PRR12 LDB1 GSE1 MIDEAS	1.63e-04	113	49	4	int:TBR1
Interaction	CBFA2T2 interactions	ATN1 CBFA2T2 RERE	1.78e-04	45	49	3	int:CBFA2T2
Interaction	SEC24A interactions	SEC24D ERBB2 SEC24A BCAR1 KHSRP	2.08e-04	224	49	5	int:SEC24A
Interaction	NFIX interactions	PRR12 PBRM1 GSE1 SMARCC2 MIDEAS	2.21e-04	227	49	5	int:NFIX
Interaction	TRIP6 interactions	ZNF384 ERBB2 ATN1 GSE1 RERE BCAR1	2.21e-04	358	49	6	int:TRIP6
Interaction	PAX7 interactions	PRR12 LDB1 GSE1 MIDEAS	2.34e-04	124	49	4	int:PAX7
Interaction	ACTC1 interactions	CHERP LRCH2 WIPF1 RBM33 SMARCC2 WIPF2 TFCP2 KHSRP	2.46e-04	694	49	8	int:ACTC1
Interaction	PAX6 interactions	PRR12 PBRM1 LDB1 GSE1 SMARCC2 MIDEAS	2.49e-04	366	49	6	int:PAX6
Interaction	SOCS6 interactions	ERBB2 IRS2 GNAS BCAR1	2.80e-04	130	49	4	int:SOCS6
Interaction	EWSR1 interactions	PRR12 SEC24D CHERP ATN1 RBM33 SEC24A PRR13 PHRF1 SMARCC2	2.93e-04	906	49	9	int:EWSR1
Interaction	SIN3A interactions	GSE1 CBFA2T2 GON4L SMARCC2 TFCP2 KHSRP	3.05e-04	380	49	6	int:SIN3A
Interaction	DOK7 interactions	EFEMP2 BCAR1	3.14e-04	11	49	2	int:DOK7
Interaction	TPRX2 interactions	PRR12 GSE1 SMARCC2	3.42e-04	56	49	3	int:TPRX2
Interaction	RBPJ interactions	ZNF384 LDB1 NFATC1 SMARCC2 NR2F2	3.71e-04	254	49	5	int:RBPJ
Interaction	SOX15 interactions	PRR12 PBRM1 LDB1 GSE1	3.81e-04	141	49	4	int:SOX15
Interaction	NFIB interactions	PRR12 LDB1 GSE1 MIDEAS	3.91e-04	142	49	4	int:NFIB
Interaction	NCK2 interactions	ERBB2 ATN1 WIPF1 BCAR1 WIPF2	4.27e-04	262	49	5	int:NCK2
Interaction	FES interactions	ERBB2 IRS2 BCAR1	4.40e-04	61	49	3	int:FES
Interaction	NR3C1 interactions	TCF7 ABCA4 PBRM1 GSE1 NFATC1 SMARCC2 IRS2 NR2F2 RBFOX2	4.97e-04	974	49	9	int:NR3C1
Interaction	TFAP4 interactions	SMARCC2 MIDEAS TFCP2 NR2F2	5.19e-04	153	49	4	int:TFAP4
Interaction	HNF4A interactions	PRR12 PBRM1 GSE1 SMARCC2 MIDEAS	5.33e-04	275	49	5	int:HNF4A
Interaction	SMC5 interactions	ZNF384 CHERP MBNL2 RBM33 SMARCC2 BCAR1 MIDEAS CCDC86 KHSRP	6.02e-04	1000	49	9	int:SMC5
Interaction	PSMA3 interactions	ATN1 PRR13 SMARCC2 RERE RBFOX2 KHSRP	6.85e-04	443	49	6	int:PSMA3
Interaction	NUP43 interactions	PBRM1 ATN1 GSE1 PHRF1 GON4L RERE MIDEAS	7.39e-04	625	49	7	int:NUP43
Interaction	BCL11B interactions	TCF7 NFATC1 NR2F2	7.76e-04	74	49	3	int:BCL11B
Interaction	SETD1B interactions	ATN1 RERE BCAR1	8.07e-04	75	49	3	int:SETD1B
Interaction	WWP2 interactions	SEC24D CHERP ATN1 WIPF1 SMARCC2 GNAS MIDEAS KHSRP	8.71e-04	840	49	8	int:WWP2
Interaction	TEAD1 interactions	PRR12 PBRM1 GSE1 MIDEAS	8.77e-04	176	49	4	int:TEAD1
Cytoband	Ensembl 112 genes in cytogenetic band chr12p13	ZNF384 KCNA5 ATN1 PRB3 PRB4	3.77e-05	353	49	5	chr12p13
Cytoband	22q12.1	CCDC117 MN1	5.42e-04	32	49	2	22q12.1
Cytoband	12p13.2	PRB3 PRB4	1.07e-03	45	49	2	12p13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr22q12	CCDC117 MN1 RBFOX2	2.05e-03	235	49	3	chr22q12
Cytoband	5q31.1	TCF7 SEC24A	2.09e-03	63	49	2	5q31.1
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	GON4L SMARCC2 RERE MIDEAS	9.38e-07	53	26	4	532
GeneFamily	Proline rich proteins	PRB3 PRB4	2.97e-05	6	26	2	972
Coexpression	OSMAN_BLADDER_CANCER_DN	COL18A1 NFATC1 RBM33 SMARCC2 RERE GNAS WIPF2	1.47e-05	431	49	7	M16858
Coexpression	GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP	NFATC1 SEC24A IRS2 MIDEAS OPLAH	3.49e-05	199	49	5	M9745
Coexpression	GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN	CCDC117 TCF7 CBFA2T2 IRS2 RERE	3.49e-05	199	49	5	M9031
Coexpression	VANASSE_BCL2_TARGETS_UP	MBNL2 GNAS NR2F2	3.53e-05	34	49	3	M1906
Coexpression	GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP	WIPF1 NFATC1 IRS2 SH2D2A MIDEAS	3.57e-05	200	49	5	M9742
Coexpression	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP	SLC35A2 IRS2 MIDEAS OPLAH KHSRP	3.57e-05	200	49	5	M9833
Coexpression	VANASSE_BCL2_TARGETS_UP	MBNL2 GNAS NR2F2	7.19e-05	43	49	3	MM799
CoexpressionAtlas	gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0	PCED1A PRR12 COL18A1 ERBB2 TCF7 CBFA2T2 PHRF1 IRS2 BCAR1 WIPF2 WNK4 KHSRP	1.93e-05	1275	48	12	gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0
ToppCell	Serous\|World / shred by cell class for bronchial biopsy	PRB3 PRB4 IRS2 GNAS WNK4	1.79e-06	184	49	5	09d0d1525c11dd326efd942684c03f79d992cf3b
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL18A1 NFATC1 SH2D2A CHPF	2.54e-05	155	49	4	7aba8ef53c9170ad8ed955c904c8991097ab1e32
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF384 PRR13 CHPF WIPF2	3.10e-05	163	49	4	d2fcd6f561748f7d29a051c504f016952ba32d0f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PCED1A SEC24D NFATC1 MBNL2	4.09e-05	175	49	4	f0c2eb82e17e8aec2cfa5d83169178f409cc1abc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PCED1A SEC24D NFATC1 MBNL2	4.09e-05	175	49	4	910a075ccaf79de22338ecf321fa0a867f3d7d75
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL18A1 KCNA5 MN1 NR2F2	4.97e-05	184	49	4	89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL18A1 KCNA5 MN1 NR2F2	4.97e-05	184	49	4	34c84ac9a32eaf96f45b79485119cad65905817d
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL18A1 KCNA5 CCDC86 NR2F2	5.18e-05	186	49	4	6568358812f0ca4e0161a1a1b29682fbced35c79
ToppCell	Control-Plasmablast\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	COL18A1 SEC24D SEC24A CHPF	5.74e-05	191	49	4	3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b
ToppCell	facs-Aorta-Heart-3m-Mesenchymal\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPP25 SEC24D IRS2 CHPF	5.86e-05	192	49	4	0dc1f46e40346ed0b286e53b106a812441575100
ToppCell	cellseq2\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRB3 PRB4 GNAS NR2F2	6.35e-05	196	49	4	d9e1b8386817a668eca90288b6d0e20be4138bf8
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL18A1 NFATC1 MAP6 MN1	6.35e-05	196	49	4	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	B_cells-Plasmablasts\|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	SEC24D MBNL2 SEC24A CHPF	6.60e-05	198	49	4	c6cab47885be74a64351f843a741dea6d911bde4
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COL18A1 EFEMP2 NR2F2 RBFOX2	6.60e-05	198	49	4	e8c0fbf306fae13e97caa294d7c99a564bd97130
ToppCell	LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T\|LPS_only / Treatment groups by lineage, cell group, cell type	TCF7 WIPF1 SH2D2A OPLAH	6.60e-05	198	49	4	584dbfeb0bb0358d3757aee56184e91ba35247ae
ToppCell	cellseq-Mesenchymal-Myocytic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL18A1 KCNA5 EFEMP2 NR2F2	6.73e-05	199	49	4	20e62a7029fa0d214244cdf2a481fc5d78290438
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRR13 GNAS CHPF WNK4	6.73e-05	199	49	4	41f3f5df41a142240947d9a57a6a282cba0c7aaa
ToppCell	wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SEC24D EFEMP2 CHPF MN1	6.73e-05	199	49	4	ab0589c068c24aa989bdca083504fbad0c15221d
ToppCell	proximal-3-mesenchymal-Pericyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL18A1 EFEMP2 BCAR1 NR2F2	6.86e-05	200	49	4	98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f
ToppCell	distal-3-mesenchymal-Pericyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL18A1 EFEMP2 BCAR1 NR2F2	6.86e-05	200	49	4	911db29f254bb697610e720ba78816e2c7f57933
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Mesenchymal\|2m / Sample Type, Dataset, Time_group, and Cell type.	COL18A1 ABCA4 KCNA5 EFEMP2	6.86e-05	200	49	4	3b9dcc9df54fb81deb7dd4b2749b1bc746c1e563
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Mesenchymal-BMP_responsible_cell\|2m / Sample Type, Dataset, Time_group, and Cell type.	COL18A1 ABCA4 KCNA5 EFEMP2	6.86e-05	200	49	4	dfad31b37e73825ed8a8278f686a48265de1aefa
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Interneuron\|2m / Sample Type, Dataset, Time_group, and Cell type.	RPP25 RERE NR2F2 RBFOX2	6.86e-05	200	49	4	08bee924a2654e05df3b39e8a51f93c8b3472175
ToppCell	proximal-mesenchymal-Pericyte\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL18A1 EFEMP2 BCAR1 NR2F2	6.86e-05	200	49	4	03119a979bc912a98e6fc87addcbc25d8ecf2fb0
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Neuron\|1m / Sample Type, Dataset, Time_group, and Cell type.	GSE1 MAP6 CBFA2T2 RBFOX2	6.86e-05	200	49	4	be1e153119ca4946b4eaef6037e8465f5c00ca6f
ToppCell	proximal-mesenchymal-Pericyte-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL18A1 EFEMP2 BCAR1 NR2F2	6.86e-05	200	49	4	a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	ERBB2 LDB1 WIPF1 NR2F2	6.86e-05	200	49	4	be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866
ToppCell	Endothelial-G\|World / shred on cell class and cell subclass (v4)	COL18A1 GNAS NR2F2	3.43e-04	124	49	3	4b72809463f2986b7d1b7ab9de633ac4d7854a92
ToppCell	Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRCH2 WNK4 NR2F2	4.31e-04	134	49	3	bffd6ce8998368d4f486b64c220eab3a44ba147b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL18A1 TCF7 LDB1	5.64e-04	147	49	3	463af96748349c8fec2911b353a7e7e4cb072280
ToppCell	(0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts\|World / Stress and Cell class	SEC24D TCF7 SLC35A2	5.64e-04	147	49	3	87c24843cb0e87ad42e725d08423131a5d2d25a3
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3\|E16.5-samps / Age Group, Lineage, Cell class and subclass	LRCH2 GSE1 NR2F2	5.87e-04	149	49	3	651494e84be03dc7b061ebdfa91756a1c507b9b4
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	COL18A1 TCF7 SH2D2A	5.98e-04	150	49	3	c922dbb4c9c12ccf08bd5f6168b20606c605d052
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	RPP25 GNAS NR2F2	6.58e-04	155	49	3	105d59d8a1bb8cb37eef2c1767d737b2108ac7c5
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 SH2D2A CHPF	6.58e-04	155	49	3	c58a5fb8d853f12204e961d633e83452eb12a659
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 SH2D2A CHPF	6.58e-04	155	49	3	9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 SH2D2A CHPF	6.58e-04	155	49	3	7a16df1a40c7255c24dfb9a921b62871554c7b6d
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 SH2D2A CHPF	6.58e-04	155	49	3	f51a12556ca0a3416a6cf0687f908fb4e752fb2f
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF384 ERBB2 OPLAH	7.08e-04	159	49	3	e967b557fe6ae4879d36f62c0297cbf6a2ad1ce9
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF384 ERBB2 OPLAH	7.08e-04	159	49	3	9db971130509c62d439e0cab16588a4d994d7aa0
ToppCell	(1)_Control_(PBS)-(4)_COL2.3+_osteoblasts\|World / Stress and Cell class	SEC24D TCF7 SLC35A2	7.21e-04	160	49	3	ab769516f9f7798d1390ef215caf22a2d3d53e63
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	COL18A1 KCNA5 NR2F2	7.34e-04	161	49	3	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL18A1 NFATC1 GNAS	7.48e-04	162	49	3	96c6e94a10b124a1d25dcd705ec5aaa8609c1089
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 SH2D2A CHPF	7.75e-04	164	49	3	9fed5df40f50bde35db8bf89c291cbdc0e104112
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 SH2D2A CHPF	7.75e-04	164	49	3	e712d6b89461f741dbd773ba9a27ecaddf97cbaa
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 MAP6 SH2D2A	7.75e-04	164	49	3	1a9b444d2c6abcc83d4355ec5228b27541df2bd0
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 WIPF1 SH2D2A	7.88e-04	165	49	3	eeb58d4db64ad37dc6b441eab22b05c24862e1a9
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL18A1 GNAS NR2F2	7.88e-04	165	49	3	347b59aa625a8a960828b8620824d8ac48990e07
ToppCell	PND03-Endothelial-Endothelial_lymphatic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL18A1 GNAS NR2F2	7.88e-04	165	49	3	1890f9c33b0c5b381d57f97042da2610a093a6de
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL18A1 GNAS NR2F2	7.88e-04	165	49	3	507c89ece0a336b8e9c65b79889a714e17ddca27
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL18A1 GNAS NR2F2	7.88e-04	165	49	3	39a25be081a5d59c7cf107a997d352793d5025fb
ToppCell	Influenza_Severe-pDC\|World / Disease group and Cell class	RPP25 KCNA5 CHPF	8.02e-04	166	49	3	bd25ce4c03c3d6cd9d986b9be1d355da52f0f2d7
ToppCell	Influenza_Severe-pDC\|Influenza_Severe / Disease group and Cell class	RPP25 KCNA5 CHPF	8.02e-04	166	49	3	b43a5cd4d28118cf6e56a435deb8ea9435608a90
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 MAP6 SH2D2A	8.16e-04	167	49	3	d30b96c39da3dd02500443877a4eb3500e26802c
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 MAP6 SH2D2A	8.16e-04	167	49	3	713899690e4acd9d259645e363c26983d6ef3022
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 ABCA4 KCNA5	8.16e-04	167	49	3	e1b1a952fce27ab9cf16919b290625ff4a75261e
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL18A1 EFEMP2 OPLAH	8.16e-04	167	49	3	f4943fb5001475ddab82a0273bcbb3fa68fdd7bd
ToppCell	Immune_cells-NK_cells\|Immune_cells / Lineage and Cell class	TCF7 SH2D2A CHPF	8.31e-04	168	49	3	125d70c37eb49eb4d1f503bb8d536b225254c7cb
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP6 MN1 RBFOX2	8.45e-04	169	49	3	2d23b4cee060f8adddc430c1c10d4e25205b4af6
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP6 MN1 RBFOX2	8.45e-04	169	49	3	ecaf08e8e0b54d1c97a02bc1f65409fd43d68227
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP6 MN1 RBFOX2	8.45e-04	169	49	3	ad6af6609acf158cb79e45ee7ca9af332be3c40c
ToppCell	368C-Myeloid-Monocyte-CD16+_Monocyte\|Monocyte / Donor, Lineage, Cell class and subclass (all cells)	SH2D2A BCAR1 RBFOX2	8.59e-04	170	49	3	4a19c7e3bb0f9c2601a10debe7000066789b4150
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL18A1 NFATC1 NR2F2	8.74e-04	171	49	3	686f95892c3909973c66c9a27159a070a068f175
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL18A1 NFATC1 NR2F2	8.74e-04	171	49	3	f7ba03e7bdb687f93782c936c7b3374cc5b3b77c
ToppCell	PND14-Endothelial-Endothelial_lymphatic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL18A1 NFATC1 NR2F2	8.74e-04	171	49	3	d0ac50071a3854d02113c455fcc940a6ec59bbb9
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF384 TCF7 SH2D2A	8.74e-04	171	49	3	f1fdc0ec3399ed6955976d02be7e5fc329a64276
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL18A1 NFATC1 NR2F2	8.74e-04	171	49	3	fbf8e9db00573adcada4b25730e191417b7c9999
ToppCell	Endothelial-Endothelial-G\|Endothelial / shred on cell class and cell subclass (v4)	COL18A1 GNAS NR2F2	8.89e-04	172	49	3	644f8e42ee8d8996f6ae50cdf874559be55509fc
ToppCell	(0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts\|(0)_Normal/No_Treatment / Stress and Cell class	SEC24D TCF7 EFEMP2	9.04e-04	173	49	3	c2a0f674681836b5a868c13f67caa7d555ef6519
ToppCell	11.5-Distal-Mesenchymal-Mesenchyme_SERPINF1-high\|Distal / Age, Tissue, Lineage and Cell class	KCNA5 CHPF MN1	9.04e-04	173	49	3	6989c9cebcd81eccceac7e5a86152676ee959386
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TCF7 WIPF1 SH2D2A	9.19e-04	174	49	3	7ebf06076946729c1af25109df6066731097c3b1
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TCF7 WIPF1 SH2D2A	9.19e-04	174	49	3	90961e8839514985712b8b986aec3391bb249ba7
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP6 EFEMP2 BCAR1	9.19e-04	174	49	3	9d5dcd46cf346c381dea68ada6665f7fb68114a3
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP6 EFEMP2 BCAR1	9.19e-04	174	49	3	53cec5c666c45278a71c21dd9c62a052a97e0fdf
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TCF7 WIPF1 SH2D2A	9.19e-04	174	49	3	c4b0987d9394f977fe6bc6a4214a6d8d73d0abcc
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPP25 ABCA4 KCNA5	9.34e-04	175	49	3	59249c9e83952d7277010e7be3c779e26399eb5d
ToppCell	facs-Skin-Anagen-24m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL18A1 NFATC1 MN1	9.34e-04	175	49	3	5552ff1e13f931c8cd7780726c90b5609497a648
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TCF7 WIPF1 SH2D2A	9.34e-04	175	49	3	8269721389a3ce98681460e6393f2cff816eaa25
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPP25 ABCA4 KCNA5	9.34e-04	175	49	3	b35cc1357495f2a03a6500f807c6e6f8c877734d
ToppCell	facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEC24D BCAR1 CHPF	9.50e-04	176	49	3	5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 WIPF1 SH2D2A	9.50e-04	176	49	3	feafc757e7aa4f17128ff34886beb2fd3461c9ea
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4\|TCGA-Lung / Sample_Type by Project: Shred V9	SEC24D WIPF1 SEC24A	9.50e-04	176	49	3	0923b01137d6f9956ca815b41102c81e82624065
ToppCell	10x3'2.3-week_14-16-Lymphocytic_T-T_NK-NK_T_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TCF7 PRB3 SH2D2A	9.50e-04	176	49	3	f0c01fc4f9c17c4d724642d9931731eef2b10258
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL18A1 EFEMP2 MN1	9.66e-04	177	49	3	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFATC1 SH2D2A CHPF	9.66e-04	177	49	3	b8de0fc92691a6d6759c743195b11edd2d63f265
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL18A1 SEC24A CHPF	9.81e-04	178	49	3	693f1135d9c5545945e80c7ba3d098afc0ccac29
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL18A1 SEC24A CHPF	9.81e-04	178	49	3	6765c6970b1f2b719a20d2afd7471e1c262f3fc4
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 MAP6 SH2D2A	9.81e-04	178	49	3	888add8935ef3aef9b6693c5698e9d1842e66337
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF7 MAP6 SH2D2A	9.81e-04	178	49	3	43eda32af2e5e28a92421612d0a4c21e5427a772
ToppCell	COVID-19-kidney-REN+Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	COL18A1 LRCH2 NR2F2	9.97e-04	179	49	3	342c1cc4444f51b8dcb30d3adc98285a25669c6e
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA4 MAP6 NR2F2	9.97e-04	179	49	3	40c65e8623547aeb80f9cd2366e29072467ce069
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL18A1 KCNA5 NR2F2	9.97e-04	179	49	3	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-TRDV2/TRGV9_gdT\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TCF7 WIPF1 SH2D2A	9.97e-04	179	49	3	f7d3d37505893ae55065c89d957084602729decc
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL18A1 LRCH2 NR2F2	9.97e-04	179	49	3	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	normal_Lymph_Node-T/NK_cells-Exhausted_CD8+_T\|normal_Lymph_Node / Location, Cell class and cell subclass	WIPF1 SH2D2A WNK4	9.97e-04	179	49	3	3dc929a10381b7d86650c6cd8f354892fe1d93e7
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Mesenchymal-Mes-Pericyte\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNA5 SH2D2A NR2F2	1.01e-03	180	49	3	e5c50d85e8df4e15f3e58f1f1d5aa25a375735de
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNA5 SH2D2A NR2F2	1.01e-03	180	49	3	f5d757786a3be20756ad8b30edd53ff80b824974
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRCH2 BCAR1 NR2F2	1.03e-03	181	49	3	e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCell	normal_Lung-Fibroblasts-Pericytes\|normal_Lung / Location, Cell class and cell subclass	COL18A1 EFEMP2 NR2F2	1.03e-03	181	49	3	f74941e49950027360d71ea3b205fc20c6929766
ToppCell	normal_Lymph_Node-T/NK_cells-Exhausted_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	WIPF1 SH2D2A WNK4	1.03e-03	181	49	3	7e12030965881b023f0d3d27d934fa648e2cc523
Drug	AG-1478; Up 200; 31.6uM; MCF7; HT_HG-U133A_EA	SEC24D MBNL2 SEC24A SLC35A2 IRS2 CHPF	2.30e-06	183	48	6	1141_UP
Drug	Guaifenesin [93-14-1]; Up 200; 20.2uM; HL60; HT_HG-U133A	ATN1 MBNL2 RERE CHPF NR2F2 KHSRP	3.42e-06	196	48	6	2569_UP
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	SEC24A CBFA2T2 EFEMP2 SLC35A2 IRS2 RERE	3.53e-06	197	48	6	7495_UP
Drug	rofecoxib; Up 200; 10uM; MCF7; HG-U133A	TCF7 WIPF1 NFATC1 MBNL2 CBFA2T2 GON4L	3.53e-06	197	48	6	205_UP
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A	TCF7 ATN1 WIPF1 EFEMP2 GON4L IRS2	3.53e-06	197	48	6	3364_DN
Drug	Diprophylline [479-18-5]; Up 200; 15.8uM; HL60; HT_HG-U133A	RPP25 NFATC1 SLC35A2 CHPF NR2F2 RBFOX2	3.53e-06	197	48	6	1853_UP
Drug	Iocetamic acid [16034-77-8]; Down 200; 6.6uM; PC3; HT_HG-U133A	RPP25 LDB1 WIPF1 CBFA2T2 EFEMP2 SH2D2A	3.63e-06	198	48	6	4600_DN
Drug	creatinine	ERBB2 ABCA4 CBFA2T2 GNAS WNK4 RBFOX2	3.98e-05	302	48	6	CID000000588
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	SEC24D ATN1 MBNL2 SLC35A2 GNAS	4.44e-05	186	48	5	2684_UP
Drug	2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A	ATN1 MBNL2 SEC24A SLC35A2 RBFOX2	5.04e-05	191	48	5	1665_UP
Drug	Orlistat; Up 200; 10uM; PC3; HT_HG-U133A	PRB4 CBFA2T2 EFEMP2 RERE GNAS	5.16e-05	192	48	5	6388_UP
Drug	Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ATN1 WIPF1 NFATC1 IRS2 GNAS	5.29e-05	193	48	5	3340_UP
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HG-U133A	COL18A1 TCF7 MBNL2 IRS2 NR2F2	5.29e-05	193	48	5	455_UP
Drug	Dapsone [80-08-0]; Up 200; 16.2uM; HL60; HT_HG-U133A	RPP25 NFATC1 CBFA2T2 EFEMP2 RBFOX2	5.42e-05	194	48	5	1868_UP
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A	ATN1 WIPF1 CBFA2T2 EFEMP2 RERE	5.42e-05	194	48	5	3384_DN
Drug	Ungerine nitrate; Down 200; 10.2uM; MCF7; HT_HG-U133A	MBNL2 CBFA2T2 SLC35A2 IRS2 GNAS	5.42e-05	194	48	5	6076_DN
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; HL60; HT_HG-U133A	RPP25 TCF7 EFEMP2 CCDC86 NR2F2	5.56e-05	195	48	5	2446_DN
Drug	Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A	SEC24D KCNA5 ATN1 WIPF1 GNAS	5.56e-05	195	48	5	4991_UP
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A	SEC24D LDB1 ATN1 EFEMP2 GON4L	5.56e-05	195	48	5	6215_UP
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A	SEC24D CBFA2T2 GON4L IRS2 MN1	5.56e-05	195	48	5	4597_DN
Drug	indomethacin, USP; Up 200; 100uM; SKMEL5; HG-U133A	CBFA2T2 EFEMP2 SH2D2A NR2F2 KHSRP	5.70e-05	196	48	5	503_UP
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; HL60; HT_HG-U133A	RPP25 ZNF384 LDB1 CBFA2T2 SMARCC2	5.70e-05	196	48	5	1311_UP
Drug	Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; HL60; HT_HG-U133A	TCF7 SEC24A GNAS WIPF2 NR2F2	5.70e-05	196	48	5	2351_DN
Drug	DO 897/99; Up 200; 8.2uM; HL60; HG-U133A	ATN1 GSE1 SH2D2A GNAS NR2F2	5.70e-05	196	48	5	1728_UP
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SEC24D TCF7 CBFA2T2 EFEMP2 RERE	5.70e-05	196	48	5	2329_DN
Drug	Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; PC3; HT_HG-U133A	LDB1 NFATC1 CBFA2T2 GON4L IRS2	5.70e-05	196	48	5	7252_UP
Drug	benserazide hydrochloride; Down 200; 10uM; SKMEL5; HG-U133A	ZNF384 CHERP LDB1 CBFA2T2 GON4L	5.70e-05	196	48	5	631_DN
Drug	monastrol; Down 200; 20uM; MCF7; HG-U133A	RPP25 GNAS WIPF2 NR2F2 KHSRP	5.70e-05	196	48	5	614_DN
Drug	Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; PC3; HT_HG-U133A	KCNA5 WIPF1 EFEMP2 IRS2 RERE	5.70e-05	196	48	5	4675_DN
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; PC3; HG-U133A	GSE1 SEC24A SH2D2A TFCP2 KHSRP	5.70e-05	196	48	5	1909_DN
Drug	Budesonide [51333-22-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	COL18A1 ERBB2 GSE1 NFATC1 CHPF	5.70e-05	196	48	5	6330_DN
Drug	Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; PC3; HT_HG-U133A	SEC24D LDB1 WIPF1 SH2D2A KHSRP	5.83e-05	197	48	5	5785_DN
Drug	Asiaticoside [16830-15-2]; Up 200; 4.2uM; PC3; HT_HG-U133A	RPP25 SEC24D CBFA2T2 IRS2 MN1	5.83e-05	197	48	5	7244_UP
Drug	Delsoline [509-18-2]; Down 200; 8.6uM; HL60; HT_HG-U133A	SEC24D TCF7 WIPF2 NR2F2 RBFOX2	5.83e-05	197	48	5	2513_DN
Drug	Nifurtimox [23256-30-6]; Up 200; 14uM; HL60; HT_HG-U133A	RPP25 TCF7 ATN1 NFATC1 RBFOX2	5.83e-05	197	48	5	2908_UP
Drug	Methantheline bromide [53-46-3]; Up 200; 9.6uM; HL60; HT_HG-U133A	COL18A1 ERBB2 ATN1 MBNL2 KHSRP	5.83e-05	197	48	5	6137_UP
Drug	Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A	ERBB2 ATN1 MBNL2 CBFA2T2 RERE	5.83e-05	197	48	5	2279_UP
Drug	Hydroflumethiazide [135-09-1]; Up 200; 12uM; PC3; HT_HG-U133A	CBFA2T2 EFEMP2 SLC35A2 GON4L IRS2	5.83e-05	197	48	5	7259_UP
Drug	Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	TCF7 IRS2 RERE CHPF NR2F2	5.98e-05	198	48	5	3483_DN
Drug	Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; HL60; HT_HG-U133A	ERBB2 NFATC1 MBNL2 CBFA2T2 RERE	5.98e-05	198	48	5	6146_UP
Drug	Probenecid [57-66-9]; Down 200; 14uM; PC3; HT_HG-U133A	RPP25 ATN1 MBNL2 RERE KHSRP	5.98e-05	198	48	5	4185_DN
Drug	Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A	LDB1 GON4L IRS2 WIPF2 RBFOX2	5.98e-05	198	48	5	2882_DN
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A	RPP25 GSE1 SMARCC2 WIPF2 NR2F2	5.98e-05	198	48	5	1299_DN
Drug	Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A	ATN1 WIPF1 RERE GNAS RBFOX2	5.98e-05	198	48	5	7325_UP
Drug	Dioxybenzone [131-53-3]; Down 200; 16.4uM; MCF7; HT_HG-U133A	COL18A1 TCF7 SLC35A2 GON4L SMARCC2	5.98e-05	198	48	5	5699_DN
Drug	Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; HL60; HT_HG-U133A	LDB1 KCNA5 ATN1 MBNL2 RBFOX2	5.98e-05	198	48	5	2472_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	CBFA2T2 GON4L RERE CHPF WIPF2	6.12e-05	199	48	5	4526_DN
Drug	genistein; Up 200; 10uM; MCF7; HG-U133A	SEC24D LDB1 WIPF1 EFEMP2 GNAS	6.12e-05	199	48	5	638_UP
Drug	Estriol [50-27-1]; Down 200; 13.8uM; PC3; HT_HG-U133A	SEC24D LDB1 SEC24A NR2F2 RBFOX2	6.12e-05	199	48	5	5866_DN
Drug	Leucomisine [17946-87-1]; Up 200; 16.2uM; HL60; HT_HG-U133A	ATN1 CBFA2T2 EFEMP2 SLC35A2 CHPF	6.12e-05	199	48	5	6125_UP
Drug	Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	WIPF1 MBNL2 GON4L IRS2 RERE	6.27e-05	200	48	5	7031_UP
Drug	indomethacin, USP; Up 200; 100uM; MCF7; HG-U133A	COL18A1 ATN1 SH2D2A NR2F2 KHSRP	6.27e-05	200	48	5	453_UP
Drug	ATN-2	ATN1 RERE	6.49e-05	6	48	2	CID003081684
Drug	PB-3	ERBB2 PBRM1 NFATC1	1.42e-04	48	48	3	CID005289109
Drug	usnic acid	SLC35A2 TFCP2	1.55e-04	9	48	2	CID000005646
Drug	N-isopropyl-p-iodoamphetamine	RERE GNAS	2.36e-04	11	48	2	CID000003729
Drug	TCDO	PBRM1 NFATC1	2.36e-04	11	48	2	CID003000391
Drug	calcium phosphate	PRB3 PRB4 RBFOX2 OPLAH	2.74e-04	149	48	4	CID000024441
Drug	tanshinone IIA	ERBB2 KCNA5 NFATC1	3.20e-04	63	48	3	CID000164676
Drug	forskolin; Up 200; 50uM; MCF7; HT_HG-U133A_EA	SEC24D WIPF1 IRS2 CHPF	3.34e-04	157	48	4	913_UP
Drug	triflate	ZNF384 PRB3 CHPF	3.83e-04	67	48	3	CID000062406
Drug	prunetin	ATN1 SLC35A2	3.90e-04	14	48	2	CID005281804
Drug	Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A	SEC24D MBNL2 SEC24A EFEMP2	3.94e-04	164	48	4	4985_UP
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	WIPF1 MBNL2 SEC24A IRS2	4.32e-04	168	48	4	1649_UP
Drug	BW-B 70C; Up 200; 31.6uM; MCF7; HT_HG-U133A_EA	MBNL2 SLC35A2 IRS2 CHPF	4.42e-04	169	48	4	1132_UP
Drug	Niclosamide [50-65-7]; Up 200; 12.2uM; PC3; HG-U133A	SEC24D MBNL2 SEC24A IRS2	4.72e-04	172	48	4	1916_UP
Drug	dimethyloxalylglycine; Up 200; 1000uM; PC3; HG-U133A	WIPF1 MBNL2 SEC24A NR2F2	4.72e-04	172	48	4	584_UP
Drug	eugenol	KCNA5 SLC35A2 BCAR1	4.93e-04	73	48	3	CID000003314
Drug	Mometasone furoate [83919-23-7]; Up 200; 7.6uM; HL60; HG-U133A	SEC24D GON4L IRS2 SH2D2A	5.04e-04	175	48	4	1746_UP
Drug	R3-G	RPP25 SLC35A2	5.13e-04	16	48	2	CID000497255
Drug	Thiostrepton [1393-48-2]; Down 200; 2.4uM; HL60; HT_HG-U133A	TCF7 GSE1 NFATC1 TFCP2	5.26e-04	177	48	4	2462_DN
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA	SEC24D WIPF1 MBNL2 IRS2	5.37e-04	178	48	4	916_UP
Drug	1,2,3-trichloropropane	BCAR1 WIPF2	5.80e-04	17	48	2	CID000007285
Drug	4,5-dioxovalerate	KCNA5 GNAS	5.80e-04	17	48	2	CID000119412
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	RPP25 GSE1 CCDC86 NR2F2	5.96e-04	183	48	4	2696_DN
Drug	Forskolin, from Coleus forskohlii; Up 200; 0.5uM; MCF7; HT_HG-U133A	SEC24D WIPF1 GON4L IRS2	6.21e-04	185	48	4	7055_UP
Drug	Securinine [5610-40-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A	MBNL2 PRB4 GNAS MN1	6.34e-04	186	48	4	6831_UP
Drug	pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A	ATN1 IRS2 SH2D2A GNAS	6.34e-04	186	48	4	5930_UP
Drug	nitrate	COL18A1 PBRM1 PRB3 RERE RBFOX2	6.46e-04	331	48	5	CID000000943
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	MBNL2 CBFA2T2 SLC35A2 IRS2	6.47e-04	187	48	4	5224_UP
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	NFATC1 MBNL2 SLC35A2 SH2D2A	6.47e-04	187	48	4	1147_UP
Drug	5182598; Down 200; 25uM; MCF7; HT_HG-U133A_EA	LDB1 CBFA2T2 SMARCC2 NR2F2	6.47e-04	187	48	4	868_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	LDB1 CCDC86 NR2F2 RBFOX2	6.60e-04	188	48	4	6186_DN
Drug	genistein; Down 200; 10uM; HL60; HT_HG-U133A	TCF7 GSE1 CCDC86 NR2F2	6.60e-04	188	48	4	1176_DN
Drug	Rescinnamin [24815-24-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A	SEC24D ATN1 WIPF1 MBNL2	6.60e-04	188	48	4	4386_UP
Drug	Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	MBNL2 CBFA2T2 IRS2 GNAS	6.60e-04	188	48	4	7466_UP
Drug	thioridazine hydrochloride; Up 200; 10uM; PC3; HT_HG-U133A	SEC24D ATN1 MBNL2 EFEMP2	6.60e-04	188	48	4	5921_UP
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	WIPF1 PRB4 GON4L IRS2	6.73e-04	189	48	4	6954_UP
Drug	clonazepam	ZNF384 ATN1 SLC35A2	6.93e-04	82	48	3	CID000002802
Drug	CP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A	KCNA5 WIPF1 IRS2 RERE	7.00e-04	191	48	4	3905_UP
Drug	Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A	ERBB2 NFATC1 IRS2 SH2D2A	7.00e-04	191	48	4	3377_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	LDB1 SMARCC2 WIPF2 NR2F2	7.00e-04	191	48	4	1225_DN
Drug	17-DMAG; Down 200; 0.1uM; PC3; HT_HG-U133A	SEC24D ATN1 SH2D2A RERE	7.00e-04	191	48	4	4437_DN
Drug	Calciferol [50-14-6]; Down 200; 10uM; PC3; HT_HG-U133A	SEC24D MBNL2 CBFA2T2 KHSRP	7.00e-04	191	48	4	6746_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	SEC24A CCDC86 NR2F2 RBFOX2	7.00e-04	191	48	4	1059_DN
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA	SLC35A2 CCDC86 NR2F2 RBFOX2	7.00e-04	191	48	4	1023_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	LDB1 MBNL2 CBFA2T2 RERE	7.00e-04	191	48	4	2937_DN
Drug	Denatonium benzoate [3734-33-6]; Down 200; 9uM; HL60; HT_HG-U133A	TCF7 CBFA2T2 GON4L RERE	7.00e-04	191	48	4	3123_DN
Drug	Cinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A	WIPF1 NFATC1 EFEMP2 RBFOX2	7.14e-04	192	48	4	2722_DN
Drug	Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SEC24D ATN1 WIPF1 SLC35A2	7.14e-04	192	48	4	3375_DN
Disease	Intellectual Disability	PRR12 COL18A1 ATN1 SLC35A2 GON4L SMARCC2 GNAS MN1	4.11e-07	447	46	8	C3714756
Disease	dentatorubral-pallidoluysian atrophy (implicated_via_orthology)	ATN1 RERE	2.38e-06	2	46	2	DOID:0060162 (implicated_via_orthology)
Disease	Intrahepatic Cholangiocarcinoma	ERBB2 PBRM1 GNAS	7.01e-06	24	46	3	C0345905
Disease	Extrahepatic Cholangiocarcinoma	ERBB2 PBRM1 GNAS	7.01e-06	24	46	3	C3805278
Disease	Cholangiocarcinoma	ERBB2 PBRM1 GNAS	8.99e-06	26	46	3	C0206698
Disease	Global developmental delay	PRR12 ATN1 SMARCC2 MN1	5.56e-05	133	46	4	C0557874
Disease	Pseudohypoaldosteronism	GNAS WNK4	1.06e-04	10	46	2	C0033805
Disease	Hyperpotassemia and Hypertension, Familial	GNAS WNK4	1.06e-04	10	46	2	C2713447
Disease	Pseudohypoaldosteronism, Type I	GNAS WNK4	1.06e-04	10	46	2	C0268436
Disease	Pseudohypoaldosteronism, Type I, Autosomal Recessive	GNAS WNK4	1.06e-04	10	46	2	C1449843
Disease	Pseudohypoaldosteronism, Type II	GNAS WNK4	1.06e-04	10	46	2	C1449844
Disease	Pseudohypoaldosteronism, Type I, Autosomal Dominant	GNAS WNK4	1.06e-04	10	46	2	C1449842
Disease	Feeding difficulties	ATN1 MN1	3.58e-04	18	46	2	C0232466
Disease	comparative body size at age 10, self-reported	NFATC1 EFEMP2 RERE GNAS RBFOX2	4.84e-04	420	46	5	EFO_0009819
Disease	osteoarthritis (biomarker_via_orthology)	NFATC1 EFEMP2	4.90e-04	21	46	2	DOID:8398 (biomarker_via_orthology)
Disease	congenital heart disease (is_implicated_in)	NFATC1 RBFOX2	6.42e-04	24	46	2	DOID:1682 (is_implicated_in)
Disease	hypothyroidism	TCF7 NFATC1 PHRF1 SH2D2A	9.98e-04	284	46	4	EFO_0004705
Disease	autoimmune thyroid disease	TCF7 SH2D2A RERE	1.01e-03	126	46	3	EFO_0006812
Disease	hyperuricemia	NFATC1 GNAS	1.22e-03	33	46	2	EFO_0009104
Disease	Mental Retardation, Psychosocial	COL18A1 GON4L GNAS	1.34e-03	139	46	3	C0025363
Disease	Profound Mental Retardation	COL18A1 GON4L GNAS	1.34e-03	139	46	3	C0020796
Disease	Mental deficiency	COL18A1 GON4L GNAS	1.34e-03	139	46	3	C0917816
Disease	response to sulfasalazine, Drug-induced agranulocytosis	GSE1 GNAS	1.53e-03	37	46	2	EFO_0008324, HP_0012235

Protein segments in the cluster

Peptide	Gene	Start	Entry
GHSQPIPTPGQPLPP	GNAS	361	P84996
GGAAPQPHPPPAFSP	ERBB2	1201	P04626
QPPQPAFPGRAFPPG	CCDC117	21	Q8IWD4
PEPYPGQQAPGPEPS	CCDC86	161	Q9H6F5
SPGAPAAHPEGQPPP	ABCA4	1321	P78363
PGPPATPAQPQPGLH	BCAR1	76	P56945
PQHFGGPPPLISPKP	GSE1	561	Q14687
NSGPPPPGAFPHPLE	ATN1	506	P54259
PQRFPGPPEFPQHTP	RBM33	416	Q96EV2
GPPEFPQHTPGPVPN	RBM33	421	Q96EV2
PPPPQNGIPTEYGVP	RBFOX2	41	O43251
GPPPGAPHTPQTPGQ	NR2F2	31	P24468
PGPHPAGPPVIQQPT	PBRM1	1576	Q86U86
ATEHPGAPPQPPPPQ	MAP6	36	Q96JE9
KEPPNGNAFPPFHPG	LDB1	21	Q86U70
PLMNPGGQFHPTPPP	CBFA2T2	276	O43439
PQDTPFFPGQPFPPH	PCED1A	341	Q9H1Q7
GPPGPPSFPGPHRQT	COL18A1	1406	P39060
PHRQTISVPGPPGPP	COL18A1	1416	P39060
PVATHPGSPGQPPPA	NFATC1	806	O95644
PSQPPPLPEGTQEPH	PHRF1	1331	Q9P1Y6
NPAFPPGGPPHPVPQ	PRR13	51	Q9NZ81
AGPTQPPHPVVPSPV	IRS2	856	Q9Y4H2
PAPHQPPAPAPGANG	KCNA5	286	P22460
PPEQPPYPHHQGGPP	CHERP	436	Q8IWX8
DGPPPHSPETPQFPP	GON4L	1971	Q3T8J9
PGTPLHPVPTFPVGP	MBNL2	106	Q5VZF2
PLQQPPPGSLGQPHP	MIDEAS	381	Q6PJG2
PPAQHPNPCPPGYEP	EFEMP2	101	O95967
PVPTLFGQPFPNGPP	LRCH2	51	Q5VUJ6
PPPQGGNQSHRPPPP	PRB4	186	P10163
GNQSHRPPPPPGKPE	PRB4	191	P10163
PVPDSFPSGPPLQHP	MN1	501	Q10571
PRQPGYQPPNPHPGP	RPP25	146	Q9BUL9
PPHAGGPPPHQYPPQ	KHSRP	531	Q92945
SVIGQGPPLPHQPPP	SH2D2A	346	Q9NP31
PTTFQPGAPHGPPPA	SEC24A	201	O95486
PPPGSPPQALAFPEH	OPLAH	1261	O14841
QPPFAQHPFVPGGPP	RERE	1031	Q9P2R6
GLQPQPPATPAVPHP	PRR12	1321	Q9ULL5
PPPGPHGPSPFPNQQ	SMARCC2	1041	Q8TAQ2
ATGHPPQRFPGPPPV	SEC24D	76	O94855
SGPCVHQQPPGQPPP	SLC35A2	356	P78381
AFHPAVAPPQGPGPP	CHPF	646	Q8IZ52
QSQGPPPHPGKPEGP	PRB3	151	Q04118
QPPPHFQSPGAAPQG	ZNF384	516	Q8TF68
GNGSPNHQPEPPPPV	TFCP2	306	Q12800
PHGGPPAVPFVVPPT	SYT15B	121	X6R8R1
PVPSPGHRSGPPEPQ	WIPF1	151	O43516
YPPPSGAGQHPQPQP	TCF7	131	P36402
PGPPPPPTFHQANTE	WIPF2	11	Q8TF74
PPPVAPGGQESPSPH	WNK4	966	Q96J92